scholarly journals A multi-step strategy to obtain crystals of the dengue virus RNA-dependent RNA polymerase that diffract to high resolution

Author(s):  
Thai Leong Yap ◽  
Yen Liang Chen ◽  
Ting Xu ◽  
Daying Wen ◽  
Subhash G. Vasudevan ◽  
...  
2011 ◽  
Vol 286 (38) ◽  
pp. 33095-33108 ◽  
Author(s):  
Michal R. Szymanski ◽  
Maria J. Jezewska ◽  
Paul J. Bujalowski ◽  
Cecile Bussetta ◽  
Mengyi Ye ◽  
...  

2013 ◽  
Vol 87 (9) ◽  
pp. 5291-5295 ◽  
Author(s):  
C. G. Noble ◽  
S. P. Lim ◽  
Y.-L. Chen ◽  
C. W. Liew ◽  
L. Yap ◽  
...  

2003 ◽  
Vol 77 (16) ◽  
pp. 8831-8842 ◽  
Author(s):  
Masako Nomaguchi ◽  
Matt Ackermann ◽  
Changsuek Yon ◽  
Shihyun You ◽  
R. Padmanbhan

ABSTRACT By using a purified dengue virus RNA-dependent RNA polymerase and a subgenomic 770-nucleotide RNA template, it was shown previously that the ratio of the de novo synthesis product to hairpin product formed was inversely proportional to increments of assay temperatures (20 to 40°C). In this study, the components of the de novo preinitiation complex are defined as ATP, a high concentration of GTP (500 μM), the polymerase, and the template RNA. Even when the 3′-terminal sequence of template RNA was mutated from -GGUUCU-3′ to -GGUUUU-3′, a high GTP concentration was required for de novo initiation, suggesting that high GTP concentration plays a conformational role. Furthermore, utilization of synthetic primers by the polymerase indicated that AGAA is the optimal primer whereas AG, AGA, and AGAACC were inefficient primers. Moreover, mutational analysis of the highly conserved 3′-terminal dinucleotide CU of the template RNA indicated that change of the 3′-terminal nucleotide from U to C reduced the efficiency about fivefold. The order of preference for the 3′-terminal nucleotide, from highest to lowest, is U, A∼G, and C. However, change of the penultimate nucleotide from C to U did not affect the template activity. A model consistent with these results is that the active site of the polymerase switches from a “closed” form, catalyzing de novo initiation through synthesis of short primers, to an “open” form for elongation of a double-stranded template-primer.


2011 ◽  
Vol 16 (2) ◽  
pp. 201-210 ◽  
Author(s):  
Pornwaratt Niyomrattanakit ◽  
Siti Nurdiana Abas ◽  
Chin Chin Lim ◽  
David Beer ◽  
Pei-Yong Shi ◽  
...  

The flaviviral RNA-dependent RNA polymerase (RdRp) is an attractive drug target. To discover new inhibitors of dengue virus RdRp, the authors have developed a fluorescence-based alkaline phosphatase–coupled polymerase assay (FAPA) for high-throughput screening (HTS). A modified nucleotide analogue (2′-[2-benzothiazoyl]-6′-hydroxybenzothiazole) conjugated adenosine triphosphate (BBT-ATP) and 3′UTR-U30 RNA were used as substrates. After the polymerase reaction, treatment with alkaline phosphatase liberates the BBT fluorophore from the polymerase reaction by-product, BBTPPi, which can be detected at excitation and emission wavelengths of 422 and 566 nm, respectively. The assay was evaluated by examining the time dependency, assay reagent effects, reaction kinetics, and signal stability and was validated with 3′dATP and an adenosine-nucleotide triphosphate inhibitor, giving IC50 values of 0.13 µM and 0.01 µM, respectively. A pilot screen of a diverse compound library of 40,572 compounds at 20 µM demonstrated good performance with an average Z factor of 0.81. The versatility and robustness of FAPA were evaluated with another substrate system, BBT-GTP paired with 3′UTR-C30 RNA. The FAPA method presented here can be readily adapted for other nucleotide-dependent enzymes that generate PPi.


2020 ◽  
Vol 94 (21) ◽  
Author(s):  
Aicha Gharbi-Ayachi ◽  
Sridhar Santhanakrishnan ◽  
Yee Hwa Wong ◽  
Kitti W. K. Chan ◽  
Siok Thing Tan ◽  
...  

ABSTRACT Zika virus (ZIKV) remains a potentially significant public health concern because it can cause teratogenic effects, such as microcephaly in newborns and neurological disease, like Guillain-Barré syndrome. Together with efforts to develop a vaccine, the discovery of antiviral molecules is important to control ZIKV infections and to prevent its most severe symptoms. Here, we report the development of small nonnucleoside inhibitors (NNIs) of ZIKV RNA-dependent RNA polymerase (RdRp) activity. These NNIs target an allosteric pocket (N pocket) located next to a putative hinge region between the thumb and the palm subdomains that was originally described for dengue virus (DENV) RdRp. We first tested the activity of DENV RdRp N-pocket inhibitors against ZIKV RdRp, introduced chemical modifications into these molecules, and assessed their potency using both enzymatic and cell-based assays. The most potent compound had a 50% inhibitory concentration value of 7.3 μM and inhibited ZIKV replication in a cell-based assay with a 50% effective concentration value of 24.3 μM. Importantly, we report four high-resolution crystal structures detailing how these NNIs insert into the N pocket of ZIKV RdRp. Our observations point to subtle differences in the size, shape, chemical environment, and hydration of the N pocket from ZIKV RdRp from those of the N pocket from DENV RdRp that are crucial for the design of improved antiviral inhibitors with activity against ZIKV. IMPORTANCE Zika virus belongs to the Flavivirus genus, which comprises several important human pathogens. There is currently neither an approved vaccine nor antiviral drugs available to prevent infection by ZIKV. The nonstructural protein 5 (NS5) polymerase, which is responsible for replicating the viral RNA genome, represents one of the most promising targets for antiviral drug development. Starting from compounds recently developed against dengue virus NS5, we designed and synthesized inhibitors targeting Zika virus NS5. We show that these novel compounds inhibit viral replication by targeting the polymerase activity. High-resolution X-ray crystallographic structures of protein-inhibitor complexes demonstrated specific binding to an allosteric site within the polymerase, called the N pocket. This work paves the way for the future structure-based design of potent compounds specifically targeting ZIKV RNA polymerase activity.


2003 ◽  
Vol 77 (19) ◽  
pp. 10730-10730 ◽  
Author(s):  
Masako Nomaguchi ◽  
Matt Ackermann ◽  
Changsuek Yon ◽  
Shihyun You ◽  
R. Padmanabhan

Il Farmaco ◽  
2001 ◽  
Vol 56 (1-2) ◽  
pp. 33-36 ◽  
Author(s):  
Subhash G. Vasudevan ◽  
Magnus Johansson ◽  
Andrew J. Brooks ◽  
Lyndon E. Llewellyn ◽  
David A. Jans

Sign in / Sign up

Export Citation Format

Share Document